Cerebrolysin vs Dihexa

Side-by-side comparison of Cerebrolysin, Dihexa — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Cerebrolysin Cerebrolysin (Porcine Brain-Derived Neuropeptide Mixture) Cognitive Dihexa Dihexa (PNB-0408) Cognitive
Basics
Molecular type Neuropeptide MixtureHGF/MET Potentiator
Amino acids ——
Molecular weight —413.5 Da
Half-life Short (hours)Long-acting (days)
Route(s) Intravenous (IV), IntramuscularOral, Transdermal, Subcutaneous (research)
Mechanism & Research
Primary mechanism Cerebrolysin's mechanism is attributed to its low-molecular-weight peptide fraction, which crosses the blood-brain barrier and exerts BDNF-like, NGF-like, and VEGF-like neurotrophic effects. It stimulates neuroplasticity… Dihexa binds to and potentiates the HGF/MET signalling axis. HGF-MET signalling drives synaptogenesis — the formation of new neural connections. By dramatically amplifying this pathway, Dihexa promotes dendritic spine de…
Research status Research Compound Research Compound
Evidence summary Cerebrolysin has one of the most extensive clinical research programmes of any nootropic compound, with over 100 controlled trials across Alzheimer's disease, stroke, TBI, and vascular dementia. Evidence is mixed across … Dihexa research is primarily from Washington State University's McCoy group. Dramatic findings in animal models have generated interest, but human clinical trials are not yet published. Anecdotal reports from users are b…
Protocol & Dosing
Typical dose 10–30 mL per session (IV); 5–10 mL IM10–15 mg/day (oral or transdermal)
Frequency Daily for 10–20 day coursesDaily or 5 days on / 2 days off
Duration 10–20 day IV course, repeated quarterly4–8 weeks
Timing MorningMorning
Safety
Common side effects
  • Injection site pain (IM)
  • Agitation or anxiety (initial — dose-dependent)
  • Headache
  • Dizziness
  • Overstimulation (anxiety, irritability at high doses)
  • Headache
  • Insomnia if taken late in day
Contraindications
  • Epilepsy/status epilepticus (can lower seizure threshold)
  • Severe renal impairment
  • Known hypersensitivity to porcine products
  • Active cancer (HGF/MET is a tumour growth pathway — significant theoretical concern)
  • Personal/family history of certain cancers (MET-driven tumours)
  • Pregnancy
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Semax, Dihexa, Selank Semax, Selank, P21
Full profile Read full Cerebrolysin profile → Read full Dihexa profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.